openPR Logo
Press release

Increasing Prevalence of Colorectal Cancer Along with Growing Geriatric Population are Likely to Impel the Growth of Colorectal Cancer Therapeutics Market in Future

11-08-2017 11:59 AM CET | IT, New Media & Software

Press release from: Research Nester Pvt Ltd

Colorectal Cancer Therapeutics Market

Colorectal Cancer Therapeutics Market

“Colorectal Cancer Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2024”

The global colorectal cancer therapeutics market is segmented into treatment type such as chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy and embolization. Among these segments, surgery segment is expected to occupy the top position in the market. Surgery is the most common treatment procedure followed by doctors to cure colorectal cancer. Surgical resection is an effective and safe procedure in order to cure colorectal cancer.

Global colorectal cancer therapeutics market is expected to register a 1.9% CAGR over the forecast period. Moreover, the global colorectal cancer therapeutics market was valued at USD 8.5 Billion in 2016 and is expected to reach at notable revenue of 9.8 Billion by the end of 2024. The expansion of the colorectal cancer therapeutics market can be attributed to a number of factors such as increasing prevalence of colorectal cancer and increasing geriatric population across the globe.

Request Free Sample Report @

https://www.researchnester.com/sample-request/2/rep-id-436

The Asia Pacific segment by region is likely to grow at remarkable pace during the forecast period. Increasing prevalence of colorectal cancer in aged population and improving healthcare infrastructure are likely to be the dynamic factors behind the growth of Asia colorectal cancer therapeutics market during the forecast period. Moreover, increasing awareness amongst the population towards colorectal cancer is also anticipated to foster the growth of market in Asia Pacific region.

Advancements in Medical Science

Increasing Research and development activities to find and develop new approaches to treat colorectal cancer which are safer, effective and possibly better than standard treatment procedures are projected to fuel the growth of global colorectal cancer therapeutics market in near future. Moreover, consumer’s inclination towards advanced treatment procedures is also expected to escalate the growth of global colorectal cancer therapeutics market.

Request Table Of Content @

https://www.researchnester.com/toc-request/1/rep-id-436

Favourable government initiatives and programmes

Favorable government initiatives to aware population about colorectal cancer and its treatment are likely to spur the expansion of global colorectal cancer therapeutics market in near future. Moreover, improving healthcare infrastructure in developing countries is anticipated to impel the growth of market during the forecast period.

Although, lack of awareness towards colorectal cancer in various undeveloped countries across the globe and reluctance in adoption of colorectal cancer medication in some regions are some of the factors that are likely to inhibit the growth of the colorectal cancer therapeutics market in the near future.

The report titled “Colorectal Cancer Therapeutics Market : Global Demand Analysis & Opportunity Outlook 2024” delivers detailed overview of the global colorectal cancer therapeutics market in terms of market segmentation by treatment, by diagnostic, by stage and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

This report also provides the existing competitive scenario of some of the key players of the global colorectal cancer therapeutics market which includes company profiling of Pfizer Inc., Bayer Healthcare Pharmaceuticals, Spectrum Pharmaceuticals Inc., Novartis AG, Amgen Inc., Merck KGaA, Invendo medical GmbH, F. Hoffmann-La Roche AG and AbbVie Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global colorectal cancer therapeutics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

To Know More Ask The Analyst @

https://www.researchnester.com/ask-the-analyst/rep-id-436

Buy This Premium Report @

https://www.researchnester.com/payment/rep-id-436

About Us:-

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact for more Info:

Ajay Daniel

Email: ajay.daniel@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Prevalence of Colorectal Cancer Along with Growing Geriatric Population are Likely to Impel the Growth of Colorectal Cancer Therapeutics Market in Future here

News-ID: 807286 • Views:

More Releases from Research Nester Pvt Ltd

Vegan Food Market: Size is Expected to Surpass USD 91.83 billion by 2035
Vegan Food Market: Size is Expected to Surpass USD 91.83 billion by 2035
Research Nester, the global vegan food market size is predicted to expand at a CAGR of 11.8% between 2026 and 2035, on account of the rising awareness of people about fitness globally. Request Free Sample Report @ https://www.researchnester.com/sample-request-6172 The Increasing Demand for Vegan Food Globally Will Increase the Global Market Share of Vegan Food Market By the end of 2035, the vegan food sector will have grown significantly and appear extremely promising. Several
U.S. Cogeneration Equipment Market Forecast to Exhibit Robust Growth During 2026-2035 | Prominent Players Include Robert BOSCH Gmbh, Siemens, General Electric, Clarke Energy
U.S. Cogeneration Equipment Market Forecast to Exhibit Robust Growth During 2026 …
The U.S. cogeneration equipment market is poised for robust advancement throughout the forecast period from 2026 to 2035, driven primarily by the nation's growing focus on energy efficiency and decarbonization. Increasing regulatory emphasis on sustainable energy use, coupled with corporate commitments to reduce carbon footprints, is stimulating widespread adoption of combined heat and power (CHP) systems across industrial, commercial, and institutional sectors. The integration of cogeneration technologies aligns with the
U.S. Coal Gasification Market Size is Expected to Witness Accelerated Expansion by 2035 | Leading Firms Such as Synthesis Energy Systems Inc., Swan Hills Synfuels LLP, Siemens AG, SEDIN Engineering Co. Ltd
U.S. Coal Gasification Market Size is Expected to Witness Accelerated Expansion …
The U.S. coal gasification market is expected to witness robust expansion during the forecast period from 2026 to 2035, driven primarily by the nation's push toward cleaner energy conversion technologies and carbon utilization strategies. The growing emphasis on decarbonizing heavy industries and enhancing domestic energy security has positioned coal gasification as a pivotal pathway for transforming coal into cleaner synthesis gas, hydrogen, and chemical feedstocks. Advancements in carbon capture and
U.S. Nuclear Fusion Market Size is Projected to Record Sustained Growth Through 2035 | Key Participants Zap Energy, TAE Technologies, Commonwealth Fusion, Helion Energy
U.S. Nuclear Fusion Market Size is Projected to Record Sustained Growth Through …
The U.S. nuclear fusion market is expected to experience strong growth throughout the forecast period from 2026 to 2035, driven primarily by technological breakthroughs in plasma confinement and increasing public-private investment in next-generation energy systems. As the country accelerates its transition toward low-carbon and sustainable power solutions, fusion energy has emerged as a promising alternative to traditional nuclear fission. Innovations in superconducting magnets, laser systems, and artificial intelligence-driven plasma control

All 5 Releases


More Releases for Colorectal

Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685 This latest report researches the
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which